{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:10:53Z","timestamp":1790863853711,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,3,7]],"date-time":"2009-03-07T00:00:00Z","timestamp":1236384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00417-009-1060-3","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T08:41:35Z","timestamp":1236328895000},"page":"1213-1221","source":"Crossref","is-referenced-by-count":120,"title":["Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"247","author":[{"given":"R. Michael","family":"Dutescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Crowston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janetta G.","family":"Culvenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,7]]},"reference":[{"key":"1060_CR1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/WNL.40.3_Part_1.439","volume":"40","author":"MF Mendez","year":"1990","unstructured":"Mendez MF, Mendez MA, Martin R, Smyth KA, Whitehouse PJ (1990) Complex visual disturbances in Alzheimer\u2019s disease. Neurology 40:439\u2013443","journal-title":"Neurology"},{"key":"1060_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000102160","volume":"58","author":"WJ Tippett","year":"2007","unstructured":"Tippett WJ, Krajewski A, Sergio LE (2007) Visuomotor integration is compromised in Alzheimer\u2019s disease patients reaching for remembered targets. Eur Neurol 58:1\u2013114. doi: 10.1159\/000102160","journal-title":"Eur Neurol"},{"key":"1060_CR3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ana.410260208","volume":"26","author":"Gary","year":"1989","unstructured":"Gary (1989) Abnormal pattern electroretinograms in patients with sede dementia of the alzheimer type. Ann Neurol 26:226\u2013231","journal-title":"Ann Neurol"},{"key":"1060_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","volume":"26","author":"PK Iseri","year":"2006","unstructured":"Iseri PK, Altinas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26:18\u201324. doi: 10.1097\/01.wno.0000204645.56873.26","journal-title":"J Neuroophthalmol"},{"key":"1060_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10384-006-0433-y","volume":"51","author":"T Ojima","year":"2007","unstructured":"Ojima T, Tanabe T, Hangai M, Yu S, Morishita S, Yoshimura N (2007) Measurement of retinal nerve fiber layer thickness and macular volume for glaucoma detection using optical coherence tomography. Jpn J Ophthalmol 51:197\u2013203. doi: 10.1007\/s10384\u2013006-0433-y","journal-title":"Jpn J Ophthalmol"},{"key":"1060_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9394(01)01196-5","volume":"133","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Keller ON, Ferrari F, Maag KP (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer\u2019s disease and Parkinson\u2019s disease. Am J Ophthalmol 133:135\u2013137. doi: 10.1016\/S0002-9394(01)01196-5","journal-title":"Am J Ophthalmol"},{"key":"1060_CR7","first-page":"1","volume":"43","author":"AB Syed","year":"2005","unstructured":"Syed AB, Armstrong RA, Smith CU (2005) A quantitative analysis of optic nerve axons in elderly control subjects and patients with Alzheimer\u2019s disease. Folia Neuropathol 43:1\u201369","journal-title":"Folia Neuropathol"},{"key":"1060_CR8","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245\u20134249. doi: 10.1073\/pnas.82.12.4245","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 1","key":"1060_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/bj2750099","volume":"275","author":"DP Hanger","year":"1991","unstructured":"Hanger DP, Brion JP, Gallo JM, Cairns NJ, Luthert PJ, Anderton BH (1991) Tau in Alzheimer\u2019s disease and Down\u2019s syndrome is insoluble and abnormally phosphorylated. Biochem J 275(Pt 1):99\u2013104","journal-title":"Biochem J"},{"key":"1060_CR10","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0196-9781(02)00063-3","volume":"23","author":"G Evin","year":"2002","unstructured":"Evin G, Weidemann A (2002) Biogenesis and metabolism of Alzheimer\u2019s disease Abeta amyloid peptides. Peptides 23:1285\u20131297. doi: 10.1016\/S0196-9781(02)00063-3","journal-title":"Peptides"},{"key":"1060_CR11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1034\/j.1600-0420.2001.790327.x","volume":"79","author":"S Janciauskiene","year":"2001","unstructured":"Janciauskiene S, Krakau T (2001) Alzheimer\u2019s peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer\u2019s disease. Acta Ophthalmol Scand 79:328\u2013329. doi: 10.1034\/j.1600-0420.2001.790327.x","journal-title":"Acta Ophthalmol Scand"},{"key":"1060_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1022949121078","volume":"106","author":"S Janciauskiene","year":"2003","unstructured":"Janciauskiene S, Krakau T (2003) Alzheimer\u2019s peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome. Doc Ophthalmol 106:215\u2013223. doi: 10.1023\/A:1022949121078","journal-title":"Doc Ophthalmol"},{"key":"1060_CR13","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1172\/JCI24635","volume":"115","author":"T Yoshida","year":"2005","unstructured":"Yoshida T, Ohno-Matsui K, Ichinose S, Sato T, Iwata N, Saido TC, Hisatomi T, Mochizuki M, Morita I (2005) The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 115:2793\u20132800. doi: 10.1172\/JCI24635","journal-title":"J Clin Invest"},{"key":"1060_CR14","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(03)12981-9","volume":"361","author":"LE Goldstein","year":"2003","unstructured":"Goldstein LE, Muffat JA, Cherny RA, Moir RD, Ericsson MH, Huang X, Mavros C, Coccia JA, Faget KY, Fitch KA, Masters CL, Tanzi RE, Chylack LT Jr, Bush AI (2003) Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer\u2019s disease. Lancet 361:1258\u20131265. doi: 10.1016\/S0140-6736(03)12981-9","journal-title":"Lancet"},{"key":"1060_CR15","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1073\/pnas.0703707104","volume":"104","author":"L Guo","year":"2007","unstructured":"Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, Moss SE, Fitzke FW, Cordeiro MF (2007) Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 104:13444\u201313449. doi: 10.1073\/pnas.0703707104","journal-title":"Proc Natl Acad Sci USA"},{"key":"1060_CR16","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1167\/iovs.06-1249","volume":"48","author":"D Goldblum","year":"2007","unstructured":"Goldblum D, Kipfer-Kauer A, Sarra GM, Wolf S, Frueh BE (2007) Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA\/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci 48:5085\u20135090. doi: 10.1167\/iovs.06-1249","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1060_CR17","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1295-1291","volume":"1","author":"C Haass","year":"1995","unstructured":"Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ (1995) The Swedish mutation causes early-onset Alzheimer\u2019s disease by beta-secretase cleavage within the secretory pathway. Nat Med 1:1291\u20131296. doi: 10.1038\/nm1295-1291","journal-title":"Nat Med"},{"key":"1060_CR18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/13383","volume":"5","author":"G Prihar","year":"1999","unstructured":"Prihar G, Verkkoniem A, Perez-Tur J, Crook R, Lincoln S, Houlden H, Somer M, Paetau A, Kalimo H, Grover A, Myllykangas L, Hutton M, Hardy J, Haltia M (1999) Alzheimer disease PS-1 exon 9 deletion defined. Nat Med 5:1090. doi: 10.1038\/13383","journal-title":"Nat Med"},{"key":"1060_CR19","doi-asserted-by":"crossref","unstructured":"Ning A, Cui JZ, To E, Hsiao Ashe K, Matsubara JA (2008) Amyloid beta deposits lead to retinal degeneration in a mouse model of alzheimer disease. Invest Ophthalmol Vis Sci","DOI":"10.1167\/iovs.08-1849"},{"key":"1060_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1471-4159.2008.05606.x","volume":"107","author":"M Shimazawa","year":"2008","unstructured":"Shimazawa M, Inokuchi Y, Okuno T, Nakajima Y, Sakaguchi G, Kato A, Oku H, Sugiyama T, Kudo T, Ikeda T, Takeda M, Hara H (2008) Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. J Neurochem 107:279\u2013290. doi: 10.1111\/j.1471-4159.2008.05606.x","journal-title":"J Neurochem"},{"key":"1060_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99\u2013102. doi: 10.1126\/science.274.5284.99","journal-title":"Science"},{"key":"1060_CR22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1389-0344(01)00067-3","volume":"17","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17:157\u2013165. doi: 10.1016\/S1389-0344(01)00067-3","journal-title":"Biomol Eng"},{"key":"1060_CR23","doi-asserted-by":"crossref","first-page":"22908","DOI":"10.1074\/jbc.271.37.22908","volume":"271","author":"N Ida","year":"1996","unstructured":"Ida N, Hartmann T, Pantel J, Schroder J, Zerfass R, Forstl H, Sandbrink R, Masters CL, Beyreuther K (1996) Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 271:22908\u201322914. doi: 10.1074\/jbc.271.37.22908","journal-title":"J Biol Chem"},{"key":"1060_CR24","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1073\/pnas.87.15.6003","volume":"87","author":"JD Buxbaum","year":"1990","unstructured":"Buxbaum JD, Gandy SE, Cicchetti P, Ehrlich ME, Czernik AJ, Fracasso RP, Ramabhadran TV, Unterbeck AJ, Greengard P (1990) Processing of Alzheimer beta\/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA 87:6003\u20136006. doi: 10.1073\/pnas.87.15.6003","journal-title":"Proc Natl Acad Sci USA"},{"key":"1060_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13506129808995285","volume":"5","author":"JG Culvenor","year":"1998","unstructured":"Culvenor JG, Henry A, Hartmann T, Evin G, Galatis D, Friedhuber A, Jayasena UL, Underwood JR, Beyreuther K, Masters CL, Cappai R (1998) Subcellular localization of the Alzheimer\u2019s disease amyloid precursor protein and derived polypeptides expressed in a recombinant yeast system. Amyloid 5:79\u201389","journal-title":"Amyloid"},{"key":"1060_CR26","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1523\/JNEUROSCI.0630-07.2007","volume":"27","author":"MT Fodero-Tavoletti","year":"2007","unstructured":"Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortes M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, Villemagne VL (2007) In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J Neurosci 27:10365\u201310371. doi: 10.1523\/JNEUROSCI.0630-07.2007","journal-title":"J Neurosci"},{"key":"1060_CR27","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)65220-0","volume":"155","author":"JG Culvenor","year":"1999","unstructured":"Culvenor JG, McLean CA, Cutt S, Campbell BC, Maher F, Jakala P, Hartmann T, Beyreuther K, Masters CL, Li QX (1999) Non-Abeta component of Alzheimer\u2019s disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid. Am J Pathol 155:1173\u20131181","journal-title":"Am J Pathol"},{"key":"1060_CR28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999) Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735\u2013741. doi: 10.1126\/science.286.5440.735","journal-title":"Science"},{"key":"1060_CR29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.10208","volume":"51","author":"RM Holsinger","year":"2002","unstructured":"Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer\u2019s disease. Ann Neurol 51:783\u2013786. doi: 10.1002\/ana.10208","journal-title":"Ann Neurol"},{"key":"1060_CR30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0197-4580(02)00153-7","volume":"24","author":"EJ Lehman","year":"2003","unstructured":"Lehman EJ, Kulnane LS, Lamb BT (2003) Alterations in beta-amyloid production and deposition in brain regions of two transgenic models. Neurobiol Aging 24:645\u2013653. doi: 10.1016\/S0197-4580(02)00153-7","journal-title":"Neurobiol Aging"},{"key":"1060_CR31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jnr.10745","volume":"74","author":"G Evin","year":"2003","unstructured":"Evin G, Zhu A, Holsinger RM, Masters CL, Li QX (2003) Proteolytic processing of the Alzheimer\u2019s disease amyloid precursor protein in brain and platelets. J Neurosci Res 74:386\u2013392. doi: 10.1002\/jnr.10745","journal-title":"J Neurosci Res"},{"key":"1060_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neulet.2007.02.090","volume":"420","author":"C Paquet","year":"2007","unstructured":"Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J (2007) Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer\u2019s disease. Neurosci Lett 420:97\u201399. doi: 10.1016\/j.neulet.2007.02.090","journal-title":"Neurosci Lett"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-009-1060-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-009-1060-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:46Z","timestamp":1559072446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-009-1060-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,7]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1007\/s00417-009-1060-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,7]]}}}